Posted by divya sawant
Filed in Health 26 views
The Plasma Therapy Market size is expected to reach US$ 950 million by 2031. The market is anticipated to register a CAGR of 11.6% during 2025–2031. Medical conditions and promote healing. PRP treatments are applied in orthopedics for joint injuries, dermatology for skin rejuvenation, and dentistry for tissue repair. Growth factors in PRP stimulate tissue regeneration, accelerating injury healing and enhancing aesthetic procedures.
Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Report Coverage: Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), Source (Autologous and Allogeneic), Application (Orthopedic Conditions, Dermatology, Dental Issues, and Others), End User (Hospitals and Clinics, Research Institutes, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America).
The plasma therapy market analysis highlights growth drivers such as rising cases of orthopedic disorders, especially in the geriatric population; increasing joint and muscle injuries in athletes; and surging demand for minimally invasive cosmetic procedures. Customization of plasma therapies according to patients’ needs is expected to introduce new trends in the market.
Rising Cases of Orthopedic Disorders & Muscle Injuries and Increasing Use of PRP in Aesthetic Procedures Fuel Plasma Therapy Market
According to statistics published by the World Health Organization (WHO) in 2023, ~528 million people across the world were living with osteoarthritis (OA) in 2019, representing an increase of 113% since 1990. PRP offers potential for tissue repair due to abundant growth factors and cytokines, which initiate and modulate regenerative microenvironments for soft and hard tissues. PRP therapy supports healing of bone fractures, ligament, muscle, and tendon injuries, peripheral nerve injuries, articular cartilage lesions, and osteoarthritis. This drives high demand for plasma therapies in orthopedic and tissue repair procedures.
PRP is also widely used in cosmetic surgeries for skin rejuvenation, anti-aging, and other aesthetic procedures. A review of 73 studies showed positive outcomes for skin rejuvenation, scar revision, alopecia, pigmentary disorders, and other conditions. Therapies were well-tolerated across phototypes, contributing significantly to market growth.
Customization Options to Introduce Patient-Centric Therapies Emerge as Future Trend in Plasma Therapy Market
Customized plasma therapy personalizes treatments based on patients’ specific medical conditions and genetic makeup. This improves efficacy by tailoring antibodies and proteins for conditions like autoimmune disorders, infectious diseases, and rare cancers. Companies provide highly pure and concentrated PRP for tissue damage healing and cell regeneration, with personalized doses for chronic pain, musculoskeletal conditions, and degenerative diseases.
Download Free Sample: https://www.theinsightpartners.com/sample/TIPRE00004429
Type-Based Insights The plasma therapy market is segmented into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure platelet-rich fibrin segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period. Leukocyte-rich PRP is associated with proinflammatory effects and can stimulate inflammation in conditions like tendinopathy.
Source-based Insights The market is bifurcated into autologous and allogeneic. The autologous segment dominated the market in 2020.
Application-based Insights By application, the market covers orthopedic conditions, dermatology, dental issues, and others. The dermatology segment held the largest market share in 2022. Orthopedic conditions segment held the largest share of 35.31% in 2022.
End User-Based Insights End users include hospitals and clinics, research institutes, and ambulatory surgical centers. The hospitals and clinics segment held the largest share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
North America dominated the plasma therapy market in 2022 and is expected to record the highest CAGR during the forecast period. The US holds the largest market share due to burgeoning adoption of PRP in orthopedic and cosmetic surgeries, rising healthcare investments, dynamic R&D landscape, and USFDA approvals for selected PRP therapies.
The global market is segmented across North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
Leading players include: BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG; CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc. These companies focus on expanding and diversifying their market presence.
Key Developments:
The Insight Partners delivers market intelligence and consulting services to help clients make informed decisions. The firm covers industries such as Aerospace and Defense, Automotive and Transportation, Semiconductor and Electronics, Biotechnology, Healthcare IT, Manufacturing, Medical Devices, Technology, Media, and Chemicals and Materials.
Contact Us
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com
Phone: +1-646-491-9876